REPEL-CV® Bioresorbable Adhesion Barrier reduces the incidence, extent and severity of post-operative cardiac adhesions.
In a randomized, controlled, clinical trial conducted at 15 pediatric cardiothoracic surgery centers, REPEL-CV Bioresorbable Adhesion Barrier was placed over the surface of the heart at the conclusion of an open heart surgery procedure to minimize the formation of post-operative adhesions. Once in place, it acts as a temporary barrier to physically separate opposing surfaces to reduce the risk of their becoming connected through the formation of fibrin bands during the early phase of wound healing. By placing REPEL-CV Adhesion Barrier between the traumatized tissue surfaces, the formation of the interconnecting fibrinous bands between adjacent surfaces is blocked and the development of fibrinous adhesions is reduced. It is then absorbed at the implant site in approximately one month.
Using REPEL-CV Adhesion Barrier minimizes the need for lengthy adhesion dissection procedures, which may reduce the length of the surgical procedure and the patient's exposure to anesthesia and its associated risks.
REPEL-CV® Adhesion Barrier features and benefits
Easy to use … Easy to prepare and apply, REPEL-CV Adhesion Barrier adds minimal time to the overall procedure. Simply cut the film to the required size, hydrate in Ringer's lactate or saline solution for a few minutes, conform the pliable film to the cardiac anatomy, and then secure it to the remaining pericardium. REPEL-CV Adhesion Barrier does not require placement on a dry surgical field.
No change in surgical procedure … Because REPEL-CV Adhesion Barrier is easily incorporated into the procedural routine, no special accommodations or training for its use are needed.
Full view of the surgical site … REPEL-CV Adhesion Barrier is a transparent film that does not impede the surgeon's full view of the surgical site during or after application, allowing visualization of key anatomical landmarks for safe and optimal placement.
Biocompatible … The polymer materials used in REPEL-CV Adhesion Barrier have been used in numerous other medical implants and are well recognized as safe and biocompatible.
Resorbable … REPEL-CV Adhesion Barrier is designed to perform the therapeutic task and then, due to exposure to moisture, degrade so that the polymer components are completely eliminated from the body in approximately one month.